Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bahar Dasgeb

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Frontiers in Medicine|March 26, 2024
Case Report: Dostarlimab for treatment of aggressive cutaneous squamous cell carcinomaSophia Gandarillas, Horace Tang, Bahar Dasgeb
Biomarkers in Cancer|November 2, 2013
Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell CarcinomaBahar Dasgeb, Tarana M Mohammadi, Darius R Mehregan
Journal of Cutaneous Pathology|March 16, 2017
Cutaneous Crohn's disease with superimposed psoriasis: A unique case with overlapping histologyBen J Friedman, Bahar Dasgeb, Jason B Lee
Seminars in Musculoskeletal Radiology|March 8, 2008
The current status of bone scintigraphy in malignant diseasesBahar Dasgeb, Michael H Mulligan, Chun K Kim
The British Journal of Radiology|August 14, 2015
Quantified ultrasound elastography in the assessment of cutaneous carcinomaBahar Dasgeb, Michael A Morris, Darius Mehregan, et al.
Journal of Cutaneous Pathology|June 21, 2019
Cancer-testis antigens as biomarkers for Merkel cell carcinoma: Pitfalls and opportunitiesBahar Dasgeb, Darius Mehregan, Christina Ring, et al.
International Journal of Dermatology|November 26, 2024
Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoidSophia Gandarillas, Adam Berger, Ryan Stephenson, et al.
International Journal of Dermatology|July 25, 2013
An introduction to primary skin imagingBahar Dasgeb, Jana Kainerstorfer, Darius Mehregan, et al.
Nuclear Medicine Communications|August 12, 2017
Finding the sweet spot for metformin in 18F-FDG-PETMichael Morris, Babak Saboury, Wengen Chen, et al.
Frontiers in Medicine|January 23, 2024
HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessmentSophia Gandarillas, Elizabeth Schoenberg Newland, Deborah Toppmeyer, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|March 26, 2024
Case Report: Dostarlimab for treatment of aggressive cutaneous squamous cell carcinomaSophia Gandarillas, Horace Tang, Bahar Dasgeb
Biomarkers in Cancer|November 2, 2013
Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell CarcinomaBahar Dasgeb, Tarana M Mohammadi, Darius R Mehregan
Journal of Cutaneous Pathology|March 16, 2017
Cutaneous Crohn's disease with superimposed psoriasis: A unique case with overlapping histologyBen J Friedman, Bahar Dasgeb, Jason B Lee
Seminars in Musculoskeletal Radiology|March 8, 2008
The current status of bone scintigraphy in malignant diseasesBahar Dasgeb, Michael H Mulligan, Chun K Kim
The British Journal of Radiology|August 14, 2015
Quantified ultrasound elastography in the assessment of cutaneous carcinomaBahar Dasgeb, Michael A Morris, Darius Mehregan, et al.
Journal of Cutaneous Pathology|June 21, 2019
Cancer-testis antigens as biomarkers for Merkel cell carcinoma: Pitfalls and opportunitiesBahar Dasgeb, Darius Mehregan, Christina Ring, et al.
International Journal of Dermatology|November 26, 2024
Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoidSophia Gandarillas, Adam Berger, Ryan Stephenson, et al.
International Journal of Dermatology|July 25, 2013
An introduction to primary skin imagingBahar Dasgeb, Jana Kainerstorfer, Darius Mehregan, et al.
Nuclear Medicine Communications|August 12, 2017
Finding the sweet spot for metformin in 18F-FDG-PETMichael Morris, Babak Saboury, Wengen Chen, et al.
Frontiers in Medicine|January 23, 2024
HLA inherence as a potential parameter in checkpoint inhibitor-associated autoimmune adverse event assessmentSophia Gandarillas, Elizabeth Schoenberg Newland, Deborah Toppmeyer, et al.
Pageof 3